Our results revealed that the proportion of CD24+/CD44+/EpCAM+/CD133+ cells differed among the cell lines and that the highest number of cells that co-expressed all of these markers was detected in the P28B cell line, which was derived from the tumor of the patient with the shortest overall survival. The gene discussed is CD24; the disease is neoplasm.